Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilson S Colucci

Showing results (81-90 of 116) with videos related to

Pageof 12
Sort By:
Nature Medicine|November 24, 2004
Adiponectin-mediated modulation of hypertrophic signals in the heartRei Shibata, Noriyuki Ouchi, Masahiro Ito, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 29, 2014
Does reversible cysteine oxidation link the Western diet to cardiac dysfunction?Jessica B Behring, Vikas Kumar, Stephen A Whelan, et al.
Journal of Molecular and Cellular Cardiology|February 8, 2018
Decreased ATP production and myocardial contractile reserve in metabolic heart diseaseIvan Luptak, Aaron L Sverdlov, Marcello Panagia, et al.
Circulation|June 20, 2007
Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trialWilson S Colucci, Theodore J Kolias, Kirkwood F Adams, et al.
European Heart Journal|September 3, 2004
Relations of plasma total TIMP-1 levels to cardiovascular risk factors and echocardiographic measures: the Framingham heart studyJohan Sundström, Jane C Evans, Emelia J Benjamin, et al.
Journal of the American College of Cardiology|July 10, 2003
Hemodynamic and clinical effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients hospitalized for acute decompensated heart failureGuillermo Torre-Amione, James B Young, Wilson S Colucci, et al.
Circulation. Heart Failure|October 11, 2013
Nitroxyl (HNO): A novel approach for the acute treatment of heart failureHani N Sabbah, Carlo Gabriele Tocchetti, Mengjun Wang, et al.
Circulation. Heart Failure|July 16, 2015
Preclinical Systolic and Diastolic Dysfunctions in Metabolically Healthy and Unhealthy Obese IndividualsYi-Chih Wang, Chang-Seng Liang, Deepa M Gopal, et al.
The Canadian Journal of Cardiology|April 19, 2007
A study to assess the effects of a broad-spectrum immune modulatory therapy on mortality and morbidity in patients with chronic heart failure: the ACCLAIM trial rationale and designGuillermo Torre-Amione, Robert C Bourge, Wilson S Colucci, et al.
Journal of the American Heart Association|March 12, 2015
Impaired right ventricular hemodynamics indicate preclinical pulmonary hypertension in patients with metabolic syndromeDeepa M Gopal, Rajalakshmi Santhanakrishnan, Yi-Chih Wang, et al.
Pageof 12

Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
Nature Medicine|November 24, 2004
Adiponectin-mediated modulation of hypertrophic signals in the heartRei Shibata, Noriyuki Ouchi, Masahiro Ito, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 29, 2014
Does reversible cysteine oxidation link the Western diet to cardiac dysfunction?Jessica B Behring, Vikas Kumar, Stephen A Whelan, et al.
Journal of Molecular and Cellular Cardiology|February 8, 2018
Decreased ATP production and myocardial contractile reserve in metabolic heart diseaseIvan Luptak, Aaron L Sverdlov, Marcello Panagia, et al.
Circulation|June 20, 2007
Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trialWilson S Colucci, Theodore J Kolias, Kirkwood F Adams, et al.
European Heart Journal|September 3, 2004
Relations of plasma total TIMP-1 levels to cardiovascular risk factors and echocardiographic measures: the Framingham heart studyJohan Sundström, Jane C Evans, Emelia J Benjamin, et al.
Journal of the American College of Cardiology|July 10, 2003
Hemodynamic and clinical effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients hospitalized for acute decompensated heart failureGuillermo Torre-Amione, James B Young, Wilson S Colucci, et al.
Circulation. Heart Failure|October 11, 2013
Nitroxyl (HNO): A novel approach for the acute treatment of heart failureHani N Sabbah, Carlo Gabriele Tocchetti, Mengjun Wang, et al.
Circulation. Heart Failure|July 16, 2015
Preclinical Systolic and Diastolic Dysfunctions in Metabolically Healthy and Unhealthy Obese IndividualsYi-Chih Wang, Chang-Seng Liang, Deepa M Gopal, et al.
The Canadian Journal of Cardiology|April 19, 2007
A study to assess the effects of a broad-spectrum immune modulatory therapy on mortality and morbidity in patients with chronic heart failure: the ACCLAIM trial rationale and designGuillermo Torre-Amione, Robert C Bourge, Wilson S Colucci, et al.
Journal of the American Heart Association|March 12, 2015
Impaired right ventricular hemodynamics indicate preclinical pulmonary hypertension in patients with metabolic syndromeDeepa M Gopal, Rajalakshmi Santhanakrishnan, Yi-Chih Wang, et al.
Pageof 12